Overview of Established Risks Associated With Rosuvastatin Use

Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, discusses her presentation at American Society of Nephrology’s Kidney Week 2021 on the known and previously established risks associated with rosuvastatin use.

Pharmacy Times interviewed Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association between rosuvastatin use with the risk of hematuria and proteinuria.

During the interview, Shin discussed what rosuvastatin is used to treat and what the known and previously established risks associated with rosuvastatin use are.